Salt Lake City, UT, US • 5 - 9 Employees
Major Drugs
GlycoMira Therapeutics is developing therapeutics for Mucosal Diseases. Current R&D focus on mitigating radiation-induced injuries (Oral Mucositis & Acute Radiation Syndrome) and chronic rhinosinusitis.